-
2013
Company Description
ABIVAX is a pioneering biotech company
ABIVAX is a pioneering biotech company. We have pioneered a unique and proprietary anti-viral platform technology, focused on the “killing” of RNA. This has already generated lead compounds for multiple viral diseases, such as Dengue and Chikungunya.
-
Manufacturer:
Science and Engineering -
Formed:
2013 -
Company Website:
-
Company E-mail:
-
Company Address:
5, rue de la BaumeParisFrance -
CEO:
- Hartmut J Ehrlich
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits